Nothing Special   »   [go: up one dir, main page]

AP9801234A0 - Cox-2 selective carprofenor treating pain and inflammation in dogs. - Google Patents

Cox-2 selective carprofenor treating pain and inflammation in dogs.

Info

Publication number
AP9801234A0
AP9801234A0 APAP/P/1998/001234A AP9801234A AP9801234A0 AP 9801234 A0 AP9801234 A0 AP 9801234A0 AP 9801234 A AP9801234 A AP 9801234A AP 9801234 A0 AP9801234 A0 AP 9801234A0
Authority
AP
ARIPO
Prior art keywords
cox
acids
activity
dogs
inhibition
Prior art date
Application number
APAP/P/1998/001234A
Other languages
English (en)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9801234A0 publication Critical patent/AP9801234A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
APAP/P/1998/001234A 1997-05-05 1998-05-04 Cox-2 selective carprofenor treating pain and inflammation in dogs. AP9801234A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
AP9801234A0 true AP9801234A0 (en) 1999-11-04

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001234A AP9801234A0 (en) 1997-05-05 1998-05-04 Cox-2 selective carprofenor treating pain and inflammation in dogs.

Country Status (32)

Country Link
EP (1) EP0988034A1 (pt)
JP (1) JP2000513020A (pt)
KR (2) KR20010012300A (pt)
CN (1) CN1255059A (pt)
AP (1) AP9801234A0 (pt)
AR (2) AR011726A1 (pt)
AU (1) AU6932198A (pt)
BG (1) BG103852A (pt)
BR (1) BR9808720A (pt)
CA (1) CA2288759A1 (pt)
DZ (1) DZ2479A1 (pt)
EA (1) EA003696B1 (pt)
GT (1) GT199800063A (pt)
HR (1) HRP980244A2 (pt)
HU (1) HUP0001286A3 (pt)
ID (1) ID21311A (pt)
IL (1) IL132570A0 (pt)
IS (1) IS5220A (pt)
MA (1) MA26491A1 (pt)
NO (1) NO995389L (pt)
NZ (1) NZ500183A (pt)
OA (1) OA11213A (pt)
PA (1) PA8450601A1 (pt)
PE (1) PE72599A1 (pt)
PL (1) PL337003A1 (pt)
SK (1) SK148199A3 (pt)
TN (1) TNSN98059A1 (pt)
TW (1) TW590773B (pt)
UY (1) UY24989A1 (pt)
WO (1) WO1998050033A1 (pt)
YU (1) YU55899A (pt)
ZA (1) ZA983722B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
ATE306263T1 (de) * 1999-03-10 2005-10-15 Searle Llc Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001087343A2 (en) * 2000-05-15 2001-11-22 Merck Frosst Canada & Co. Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
AU6837701A (en) 2000-06-13 2001-12-24 American Home Prod Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
ATE420201T1 (de) 2000-08-07 2009-01-15 Univ Vanderbilt Nachweis der cox-2 aktivität und von anandamid- metaboliten
AU2002354901A1 (en) * 2001-07-16 2003-03-03 Edward Hogestatt Compounds with analgesic, antipyretic and/or anti-inflammatory activity
PL2266585T3 (pl) 2003-05-07 2013-10-31 Osteologix As Rozpuszczalne w wodzie sole stronktu do stosowania w leczeniu chorób chrząstki i/lub kości
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
AU2006248645A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
US8535713B2 (en) 2007-04-04 2013-09-17 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
EP2061587A1 (en) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Manufacture of multiple minicapsules
PL2471518T3 (pl) 2009-05-18 2018-01-31 Sigmoid Pharma Ltd Kompozycja zawierająca kropelki oleju
EP2464341B1 (en) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
ES2907285T3 (es) 2014-03-06 2022-04-22 Elanco Animal Health Incorporated Composiciones de grapiprant y procedimientos de uso de las mismas
PL3215127T3 (pl) 2014-11-07 2021-05-17 Sublimity Therapeutics Limited Kompozycje zawierające cyklosporynę
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
AU2016205145A1 (en) * 2015-01-09 2017-07-13 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
IS5220A (is) 1999-10-19
PE72599A1 (es) 1999-08-12
KR20010012300A (ko) 2001-02-15
GT199800063A (es) 1999-10-26
IL132570A0 (en) 2001-03-19
HUP0001286A3 (en) 2000-12-28
JP2000513020A (ja) 2000-10-03
HRP980244A2 (en) 1999-02-28
PA8450601A1 (es) 2000-05-24
NO995389L (no) 2000-01-04
AR011726A1 (es) 2000-08-30
OA11213A (en) 2003-07-14
YU55899A (sh) 2003-08-29
CA2288759A1 (en) 1998-11-12
ZA983722B (en) 1999-11-04
TW590773B (en) 2004-06-11
DZ2479A1 (fr) 2003-02-01
CN1255059A (zh) 2000-05-31
KR20040004406A (ko) 2004-01-13
EP0988034A1 (en) 2000-03-29
NO995389D0 (no) 1999-11-04
AU6932198A (en) 1998-11-27
ID21311A (id) 1999-05-20
TNSN98059A1 (fr) 2005-03-15
BG103852A (en) 2000-06-30
WO1998050033A1 (en) 1998-11-12
BR9808720A (pt) 2000-07-11
NZ500183A (en) 2002-04-26
SK148199A3 (en) 2001-09-11
HUP0001286A2 (hu) 2000-11-28
EA003696B1 (ru) 2003-08-28
PL337003A1 (en) 2000-07-31
EA199900895A1 (ru) 2000-06-26
UY24989A1 (es) 2001-10-25
AR039628A2 (es) 2005-03-02
MA26491A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
AP9801234A0 (en) Cox-2 selective carprofenor treating pain and inflammation in dogs.
NZ330860A (en) Method of inhibiting photoaging of skin
HK1034189A1 (en) An acidified composition for topical treatment of nail and skin conditions.
EE04416B1 (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
EA200000825A1 (ru) Композиция, включающая ингибитор il-1 и полимер, контролирующий высвобождение
BG104476A (en) Therapeutical form for tolterodin with controlled release
WO1996018391A3 (en) Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
WO2000028980A3 (en) Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
CA2379649A1 (en) The use of conjugated linoleic acid for the selective inhibition of cyclooxygenase-2
DE50014190D1 (de) Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
NO985575L (no) FremgangsmÕter og preparater anvendelige for inhibering av <alfa>v<beta>5-mediert angiogenese
NO20002440D0 (no) Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
BR0011172A (pt) Derivados do 4,5-diaril-3(2h)-furanona como inibidores de cliclooxigenase-2
AU3346095A (en) Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
DK0782441T3 (da) Farmaceutisk kontrol af inflammation
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
MA26777A1 (fr) Inhibiteurs d'aminotransferase dependante d'aminoacide en chaine ramifiee et leur usage dans le traitement de la retinopathie diabetique.
SE9803761D0 (sv) Method to avoid increased iridial pigmentation during prostaglandin treatment
ZA978400B (en) Use of inhibitors of the activity of retinoic acid to promote healing.
CO5021216A1 (es) Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros
HUP0001097A2 (hu) COMT-inhibitorok alkalmazása cukorbetegséggel kapcsolatos érrendszeri rendellenességek megelőzésére alkalmas gyógyszerkészítmények előállítására
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
NO20001812L (no) Gallesyresalter av metaller med fysiologisk virkning, samt terapeutisk anvendelse derav
BR0213634A (pt) Sistema de liberação de droga com ação retardada para um agente antiespasmódico
ATE286892T1 (de) Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität